The epidemiology of Staphylococcus hominis:Â
Distribution: Staphylococcus hominis is widely distributed and can be found on healthy individuals’ skin and mucous membranes. It is a member of the human microbiota, particularly in the axilla, groin, and perineal areas.Â
Colonization and Transmission: Staphylococcus hominis can colonize the skin and mucous membranes through direct contact with contaminated surfaces or through person-to-person transmission. It can also be acquired from healthcare settings, especially in individuals with weakened immune systems.Â
Opportunistic Infections: Staphylococcus hominis can cause various opportunistic infections, especially for those with weakened immune systems, such as those with underlying medical conditions, surgical patients, or indwelling medical devices like catheters. Common infections include:Â
Antibiotic Resistance: Like other Staphylococcus species, Staphylococcus hominis could develop antibiotic resistance. It has been associated with antibiotic resistance, including methicillin-resistant Staphylococcus hominis (MRSH). It can complicate treatment and increase the risk of healthcare-associated infections.Â
Hospital-Associated Infections: Staphylococcus hominis is often implicated in healthcare-associated infections, particularly in intensive care units (ICUs) and other healthcare settings. These infections can be challenging to treat due to antibiotic-resistant strains and the potential for the organism to form biofilms on medical devices.Â
Staphylococcus hominis is a species of bacteria that belongs to the genus Staphylococcus and the family Staphylococcaceae. Here is the taxonomical classification of Staphylococcus hominis:Â
Kingdom: BacteriaÂ
Phylum: BacillotaÂ
Class: BacilliÂ
Order: BacillalesÂ
Family: StaphylococcaceaeÂ
Genus: StaphylococcusÂ
Species: S. hominisÂ
the structure of Staphylococcus hominis:Â
Cell Wall: Like other Gram-positive bacteria, Staphylococcus hominis has a thick cell wall composed of peptidoglycan. The peptidoglycan layer provides structural support and protection for the bacterium.Â
Cell Membrane: Beneath the cell wall is a plasma membrane separating the bacterium’s internal components from the external environment. It controls how molecules enter and exit the body of the cell.Â
Capsule: Some strains of Staphylococcus hominis may possess a polysaccharide capsule outside the cell wall. The capsule helps the bacterium evade the host immune system by impairing phagocytosis and can contribute to virulence.Â
Cytoplasm: Inside the cell membrane, Staphylococcus hominis contains cytoplasm, which houses various cellular components such as DNA, ribosomes, enzymes, and other proteins necessary for cellular functions.Â
Surface Structures: Staphylococcus hominis has numerous surface structures, including proteins and polysaccharides, which play essential roles in adhesion, colonization, and immune evasion. These structures can vary among different strains.Â
The antigenic types of S. hominis have yet to be well studied, but some studies have reported the presence of antimicrobial peptides and antibiotic-resistance genes in this species. These factors may contribute to the pathogenicity and virulence of S. hominis in certain conditions. Staphylococcus hominis can be divided into two subspecies: S. hominis subsp. hominis & S. hominis subsp. novobiosepticus. These subspecies can be identified by their novobiocin susceptibility and their habitat. S. hominis subsp. hominis is susceptible to novobiocin, whereas S. hominis subsp. novobiosepticus is not susceptible to novobiocin.
Besides novobiocin susceptibility, these subspecies can also be distinguished by their SDS-PAGE or MALDI-TOF MS profiles. These methods can detect differences in the two subspecies’ protein patterns or mass spectra. Another way to identify S. hominis subspecies is by their trehalose fermentation ability. Unlike S. epidermidis, S. hominis produces acid from trehalose, so the two tests together identify the species. However, some strains of S. hominis subsp. novobiosepticus can also ferment trehalose, considered atypical phenotypic results for this subspecies.Â
The pathogenesis of S. hominis infection is not fully understood, but it may involve multiple factors, such as:Â
The host defenses of S. hominis infection may include the following:Â
The symptoms of the location and severity of an infection with S. hominis. Some of the possible symptoms are:Â
Â
the following tests to identify a staph infection:Â
Some specific tests that can help identify S. hominis are:Â
Some of the ways to prevent Staphylococcus hominis infection are:Â
The epidemiology of Staphylococcus hominis:Â
Distribution: Staphylococcus hominis is widely distributed and can be found on healthy individuals’ skin and mucous membranes. It is a member of the human microbiota, particularly in the axilla, groin, and perineal areas.Â
Colonization and Transmission: Staphylococcus hominis can colonize the skin and mucous membranes through direct contact with contaminated surfaces or through person-to-person transmission. It can also be acquired from healthcare settings, especially in individuals with weakened immune systems.Â
Opportunistic Infections: Staphylococcus hominis can cause various opportunistic infections, especially for those with weakened immune systems, such as those with underlying medical conditions, surgical patients, or indwelling medical devices like catheters. Common infections include:Â
Antibiotic Resistance: Like other Staphylococcus species, Staphylococcus hominis could develop antibiotic resistance. It has been associated with antibiotic resistance, including methicillin-resistant Staphylococcus hominis (MRSH). It can complicate treatment and increase the risk of healthcare-associated infections.Â
Hospital-Associated Infections: Staphylococcus hominis is often implicated in healthcare-associated infections, particularly in intensive care units (ICUs) and other healthcare settings. These infections can be challenging to treat due to antibiotic-resistant strains and the potential for the organism to form biofilms on medical devices.Â
Staphylococcus hominis is a species of bacteria that belongs to the genus Staphylococcus and the family Staphylococcaceae. Here is the taxonomical classification of Staphylococcus hominis:Â
Kingdom: BacteriaÂ
Phylum: BacillotaÂ
Class: BacilliÂ
Order: BacillalesÂ
Family: StaphylococcaceaeÂ
Genus: StaphylococcusÂ
Species: S. hominisÂ
the structure of Staphylococcus hominis:Â
Cell Wall: Like other Gram-positive bacteria, Staphylococcus hominis has a thick cell wall composed of peptidoglycan. The peptidoglycan layer provides structural support and protection for the bacterium.Â
Cell Membrane: Beneath the cell wall is a plasma membrane separating the bacterium’s internal components from the external environment. It controls how molecules enter and exit the body of the cell.Â
Capsule: Some strains of Staphylococcus hominis may possess a polysaccharide capsule outside the cell wall. The capsule helps the bacterium evade the host immune system by impairing phagocytosis and can contribute to virulence.Â
Cytoplasm: Inside the cell membrane, Staphylococcus hominis contains cytoplasm, which houses various cellular components such as DNA, ribosomes, enzymes, and other proteins necessary for cellular functions.Â
Surface Structures: Staphylococcus hominis has numerous surface structures, including proteins and polysaccharides, which play essential roles in adhesion, colonization, and immune evasion. These structures can vary among different strains.Â
The antigenic types of S. hominis have yet to be well studied, but some studies have reported the presence of antimicrobial peptides and antibiotic-resistance genes in this species. These factors may contribute to the pathogenicity and virulence of S. hominis in certain conditions. Staphylococcus hominis can be divided into two subspecies: S. hominis subsp. hominis & S. hominis subsp. novobiosepticus. These subspecies can be identified by their novobiocin susceptibility and their habitat. S. hominis subsp. hominis is susceptible to novobiocin, whereas S. hominis subsp. novobiosepticus is not susceptible to novobiocin.
Besides novobiocin susceptibility, these subspecies can also be distinguished by their SDS-PAGE or MALDI-TOF MS profiles. These methods can detect differences in the two subspecies’ protein patterns or mass spectra. Another way to identify S. hominis subspecies is by their trehalose fermentation ability. Unlike S. epidermidis, S. hominis produces acid from trehalose, so the two tests together identify the species. However, some strains of S. hominis subsp. novobiosepticus can also ferment trehalose, considered atypical phenotypic results for this subspecies.Â
The pathogenesis of S. hominis infection is not fully understood, but it may involve multiple factors, such as:Â
The host defenses of S. hominis infection may include the following:Â
The symptoms of the location and severity of an infection with S. hominis. Some of the possible symptoms are:Â
Â
the following tests to identify a staph infection:Â
Some specific tests that can help identify S. hominis are:Â
Some of the ways to prevent Staphylococcus hominis infection are:Â
The epidemiology of Staphylococcus hominis:Â
Distribution: Staphylococcus hominis is widely distributed and can be found on healthy individuals’ skin and mucous membranes. It is a member of the human microbiota, particularly in the axilla, groin, and perineal areas.Â
Colonization and Transmission: Staphylococcus hominis can colonize the skin and mucous membranes through direct contact with contaminated surfaces or through person-to-person transmission. It can also be acquired from healthcare settings, especially in individuals with weakened immune systems.Â
Opportunistic Infections: Staphylococcus hominis can cause various opportunistic infections, especially for those with weakened immune systems, such as those with underlying medical conditions, surgical patients, or indwelling medical devices like catheters. Common infections include:Â
Antibiotic Resistance: Like other Staphylococcus species, Staphylococcus hominis could develop antibiotic resistance. It has been associated with antibiotic resistance, including methicillin-resistant Staphylococcus hominis (MRSH). It can complicate treatment and increase the risk of healthcare-associated infections.Â
Hospital-Associated Infections: Staphylococcus hominis is often implicated in healthcare-associated infections, particularly in intensive care units (ICUs) and other healthcare settings. These infections can be challenging to treat due to antibiotic-resistant strains and the potential for the organism to form biofilms on medical devices.Â
Staphylococcus hominis is a species of bacteria that belongs to the genus Staphylococcus and the family Staphylococcaceae. Here is the taxonomical classification of Staphylococcus hominis:Â
Kingdom: BacteriaÂ
Phylum: BacillotaÂ
Class: BacilliÂ
Order: BacillalesÂ
Family: StaphylococcaceaeÂ
Genus: StaphylococcusÂ
Species: S. hominisÂ
the structure of Staphylococcus hominis:Â
Cell Wall: Like other Gram-positive bacteria, Staphylococcus hominis has a thick cell wall composed of peptidoglycan. The peptidoglycan layer provides structural support and protection for the bacterium.Â
Cell Membrane: Beneath the cell wall is a plasma membrane separating the bacterium’s internal components from the external environment. It controls how molecules enter and exit the body of the cell.Â
Capsule: Some strains of Staphylococcus hominis may possess a polysaccharide capsule outside the cell wall. The capsule helps the bacterium evade the host immune system by impairing phagocytosis and can contribute to virulence.Â
Cytoplasm: Inside the cell membrane, Staphylococcus hominis contains cytoplasm, which houses various cellular components such as DNA, ribosomes, enzymes, and other proteins necessary for cellular functions.Â
Surface Structures: Staphylococcus hominis has numerous surface structures, including proteins and polysaccharides, which play essential roles in adhesion, colonization, and immune evasion. These structures can vary among different strains.Â
The antigenic types of S. hominis have yet to be well studied, but some studies have reported the presence of antimicrobial peptides and antibiotic-resistance genes in this species. These factors may contribute to the pathogenicity and virulence of S. hominis in certain conditions. Staphylococcus hominis can be divided into two subspecies: S. hominis subsp. hominis & S. hominis subsp. novobiosepticus. These subspecies can be identified by their novobiocin susceptibility and their habitat. S. hominis subsp. hominis is susceptible to novobiocin, whereas S. hominis subsp. novobiosepticus is not susceptible to novobiocin.
Besides novobiocin susceptibility, these subspecies can also be distinguished by their SDS-PAGE or MALDI-TOF MS profiles. These methods can detect differences in the two subspecies’ protein patterns or mass spectra. Another way to identify S. hominis subspecies is by their trehalose fermentation ability. Unlike S. epidermidis, S. hominis produces acid from trehalose, so the two tests together identify the species. However, some strains of S. hominis subsp. novobiosepticus can also ferment trehalose, considered atypical phenotypic results for this subspecies.Â
The pathogenesis of S. hominis infection is not fully understood, but it may involve multiple factors, such as:Â
The host defenses of S. hominis infection may include the following:Â
The symptoms of the location and severity of an infection with S. hominis. Some of the possible symptoms are:Â
Â
the following tests to identify a staph infection:Â
Some specific tests that can help identify S. hominis are:Â
Some of the ways to prevent Staphylococcus hominis infection are:Â

Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.

On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.

When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
